Neftaly 100 Proposals for ARPA‑H Ocular Laboratory for Analysis of Biomarkers (OLAB) Program

Designed to meet ARPA‑H’s high‑risk, high‑impact goals, accelerate translational research, and create a modular, cloud‑connected ocular biomarker platform.
1‑10 Foundational Infrastructure & Platforms

1. Integrated Ocular Biomarker Data Commons (IOBDC) – FAIR‑compliant repository linking imaging, genomics, metabolomics, and clinical data.
2. Modular Ocular Lab‑on‑a‑Chip (MOLC) – Reconfigurable microfluidic cartridges for tear, aqueous humor, and vitreous sampling.
3. Secure Ocular Research & Innovation Platform (SORIP) – Zero‑trust cloud environment with consent‑managed data sharing.
4. Standardized Ocular Biomarker Ontology (SOBO) – Extension of OBO Foundry for eye‑specific analytes and phenotypes.
5. Automated Sample Handling & Processing Unit (ASHP) – Robotic liquid handlers integrated with barcode tracking.
6. Remote Multi‑Modal Imaging Suite (RMIS) – Portable OCT, fundus autofluorescence, and adaptive optics for tele‑ophthalmology.
7. Real‑Time Biomarker Analytics Engine (RBAE) – Edge‑computing AI for on‑device analysis of tear cytokines.
8. Digital Twin of Ocular Physiology (DTOP) – Multi‑scale simulation (molecular → tissue) for hypothesis testing.
9. Open‑Source Ocular Data Annotation Tool (OODAT) – Collaborative annotation for pathology segmentation.
10. Interoperable Clinical Endpoint Registry (ICER) – Curated endpoints for diabetic retinopathy, AMD, glaucoma, and dry‑eye disease.
    11‑20 Biomarker Discovery & Validation
11. Tear Proteomics Signature for Early AMD – Longitudinal cohort, label‑free quantification, and machine‑learning classifier.
12. Metabolomic Profiling of Aqueous Humor in Glaucoma – Targeted LC‑MS/MS panel for oxidative stress metabolites.
13. Circulating Micro‑RNA Biomarkers for Retinal Vascular Occlusion – Small‑RNA sequencing of plasma exosomes.
14. Autoantibody Array for Uveitis Subtyping – Multiplex bead assay for novel antigenic targets.
15. Retinal Cell‑Specific Extracellular Vesicles (EVs) Cargo Analysis – Single‑EV sequencing for disease‑specific RNA.
16. Longitudinal Tear Osmolarity Variability Endpoint – Continuous wearable sensor validation in dry‑eye trials.
17. Optical Coherence Tomography Angiography (OCTA) Quantitative Biomarker Suite – Vessel density, fractal dimension, and foveal avascular zone metrics.
18. Multiplexed Immunoassay for Inflammatory Cytokines in Tear Film – Simultaneous measurement of IL‑6, TNF‑α, IL‑1β, and MMP‑9.
19. Glycomic Profiling of Vitreous Humor in Proliferative Diabetic Retinopathy – Lectin‑array and mass‑spec workflow.
20. AI‑Driven Retinal Layer Thickness Deviation Mapping – Deviation from normative database for early glaucoma detection.
    21‑30 Advanced Sensing & Wearable Technologies
21. Smart Contact Lens for Continuous Intraocular Pressure (IOP) Monitoring – Wireless, nano‑sensor with smartphone readout.
22. Tear‑Based Glucose Biosensor – Non‑invasive, enzymatic strip integrated with handheld reader.
23. Multispectral Fundus Camera in a Pocket – Low‑cost, portable device for retinal pigment epithelium (RPE) health assessment.
24. Dynamic Pupillometry Wearable (DPW) – Infrared pupillometer for autonomic dysfunction biomarker.
25. Implantable Fluorescent Biomarker Sensor – Sub‑conjunctival device for real‑time VEGF or complement factor detection.
26. Smartphone‑Based Anterior Segment Analyzer – Attachable slit‑lamp module for corneal nerve imaging.
27. Handheld OCT Probe for Point‑of‑Care Retinal Screening – Battery‑operated, 3‑µm resolution.
28. Tear Film Stability Analyzer (TFSA) – Interferometry for lipid layer thickness and breakup time.
29. Wearable Ocular Surface Temperature Monitor – Flexible patch for dry‑eye inflammation tracking.
30. Smart Spectacles for Visual Field Testing – Eye‑tracking and perimetry via augmented reality lenses.
    31‑40 Artificial Intelligence & Computational Tools
31. Deep Learning Pipeline for Retinal Lesion Classification – Multi‑label CNN for drusen, hemorrhage, and neovascularization.
32. Predictive Risk Model for Diabetic Macular Edema (DME) – Integrates EHR, imaging, and biomarker data.
33. Reinforcement Learning for Personalized Treatment Regimens – Adaptive anti‑VEGF dosing based on OCT response.
34. Explainable AI for Glaucoma Progression Mapping – Feature attribution linking RNFL thickness to visual field loss.
35. Natural Language Processing Engine for Ocular Clinical Notes – Extracts structured endpoints from unstructured text.
36. Synthetic Ocular Imaging Dataset Generator – GANs for rare disease cases to augment training data.
37. Automated OCT Layer Segmentation with Uncertainty Quantification – Provides confidence intervals for clinical decision support.
38. Federated Learning Platform for Multi‑Center Retinal Biomarker Discovery – Privacy‑preserving model training across sites.
39. Digital Pathology Slide Analysis for Ocular Tumors – Whole‑slide imaging, nuclei detection, and prognostic scoring.
40. Clinical Trial Simulation Tool (CTST) – In‑silico trial design for ocular gene‑therapy studies.
    41‑50 Therapeutic Target & Drug Development
41. CRISPR‑Based Gene Editing for Leber Congenital Amaurosis – Non‑viral delivery system using lipid nanoparticles.
42. Nanobody‑Conjugated Photodynamic Therapy for Choroidal Neovascularization – Targeted to VEGF‑A isoforms.
43. Small‑Molecule Complement Inhibitor for Geographic Atrophy – Oral drug candidate with ocular tissue penetration.
44. Stem‑Cell Derived Retinal Pigment Epithelium Patch for Dry AMD – GMP‑compliant manufacturing and cryopreservation protocol.
45. Micro‑RNA Replacement Therapy for Diabetic Retinopathy – Nanocarrier delivering miR‑146a mimic.
46. Neuroprotective Peptide for Glaucoma Optic Neuropathy – Blood‑retinal barrier‑crossing peptide with sustained release depot.
47. Targeted Drug Delivery via Hyaluronic‑Acid Nanoparticles – Preferential uptake by retinal Müller cells.
48. Ocular Gene Therapy Vector Library – AAV serotype screening platform for optimal transduction efficiency.
49. In‑Vitro Pharmacokinetic Model of Ocular Tissues – 3D bioprinted cornea‑sclera‑retina interface for drug diffusion studies.
50. High‑Throughput Screening Assay for Anti‑Angiogenic Compounds – Endothelial cell tube formation using retinal microvascular cells.
    51‑60 Clinical Endpoint & Outcome Measures
51. Patient‑Reported Ocular Symptom Score (PROSS) – Digital PRO with daily symptom severity and impact.
52. Visual Function Questionnaire for Low‑Vision (VFQ‑LV) – Adaptive, Rasch‑analyzed short form for clinical trials.
53. Composite Ocular Disease Activity Index (CODAI) – Integrates imaging, biomarker, and PRO data.
54. Reading Speed & Eye‑Movement Endpoint (RSEE) – Eye‑tracking tablet for functional vision assessment.
55. Contrast Sensitivity Test on Smartphone Platform – Adaptive staircase for remote monitoring.
56. Dark Adaptation Kinetics Endpoint – Portable device measuring rod recovery time.
57. Ocular Surface Disease Index (OSDI) Mobile App – Real‑time scoring and longitudinal tracking.
58. Microperimetry Biomarker for Macular Degeneration – Mean sensitivity loss mapping for early detection.
59. Pupillary Light Reflex Variability Endpoint – Wearable pupillometer for autonomic dysfunction.
60. Retinal Vessel Caliber Change Endpoint – Semi‑automated measurement from fundus photos.
    61‑70 Regulatory & Reimbursement Strategy
61. FDA Breakthrough Device Pathway Blueprint for Ocular Biosensors – Gap analysis and evidence plan.
62. CMS Reimbursement Code Set for Remote Ocular Monitoring – CPT/ HCPCS code proposal for wearable IOP sensor.
63. Real‑World Evidence Registry for Anti‑VEGF Therapies – Standardized data collection for post‑market safety.
64. Digital Health Trust Certification Framework – Security, privacy, and usability criteria for cloud‑based platforms.
65. **_International Harmonization Roadmap for O
    

.
66‑70 Regulatory & Reimbursement Strategy (cont’d)

66. International Harmonization Roadmap for Ocular Biomarker Standards – Align with WHO, EMA, and ICH guidelines; draft common technical document (CTD) modules.
67. Value‑Based Pricing Model for Ocular Diagnostic Platform – Cost‑effectiveness analysis linking biomarker results to reduced disease burden.
68. Regulatory Sandbox for Rapid‑Cycle Innovation – Pilot with FDA’s Emerging Technology Program for iterative device upgrades.
69. Stakeholder Engagement Toolkit for Payer Negotiations – Evidence dossiers, budget‑impact models, and health‑economic outcomes.
70. Post‑Market Surveillance & Real‑World Evidence Platform – Cloud‑based data pipeline feeding FDA’s Sentinel system.
    71‑80 Data Sharing & Open Science Initiatives
71. Ocular Biomarker Data Enclave (OBDE) – Secure, HIPAA‑compliant enclave for multi‑site data analysis.
72. Open‑API Gateway for Ocular Sensor Integration – Standardized FHIR‑based endpoints for device manufacturers.
73. Data Use Agreement (DUA) Automation Engine – AI‑driven contract generation and compliance tracking.
74. Global Ocular Biomarker Consortium (GOBC) – Multi‑national partnership for pooled cohort creation.
75. Pre‑Competitive Data Sharing Platform – Shared datasets for algorithm benchmarking and validation.
76. Public‑Access Ocular Imaging Archive (PAOIA) – Curated, de‑identified OCT and fundus image library.
77. Citizen‑Science Ocular Health Portal – Volunteers upload smartphone retinal images for crowd‑sourced analysis.
78. Standardized Informed Consent for Biomarker Research – Machine‑readable consent with dynamic revocation options.
79. Blockchain‑Based Provenance Ledger for Biomarker Assays – Immutable audit trail for assay validation.
80. Data Quality Assurance Dashboard – Real‑time metrics on completeness, accuracy, and timeliness.
    81‑90 Workforce Development & Training
81. Ocular Biomarker Scientist Fellowship Program – Two‑year post‑doc training with industry mentorship.
82. Hands‑On Microfluidics Workshop for Clinicians – Short‑course on tear‑based assay development.
83. Digital Ophthalmology Certification Course – Online modules + virtual lab practicum for ophthalmology residents.
84. AI for Ocular Imaging Bootcamp – Collaborative coding challenges using open datasets.
85. Regulatory Affairs & Reimbursement Training Pipeline – Partner with academic centers and industry experts.
86. Diversity & Inclusion Scholarships for Underrepresented Researchers – Funding for minority students to attend OLAB summer school.
87. Interdisciplinary Exchange Program (Ophthalmology ↔ Engineering) – 3‑month rotations in partner labs.
88. Continuing Medical Education (CME) Series on Emerging Biomarkers – Live webinars with Q&A from leading investigators.
89. Patient Advocacy & Community Engagement Fellowship – Train patients as research partners (Patient‑Centered Outcomes Research).
90. Mentorship Network for Early‑Career Investigators – Structured pairing with senior scientists and industry mentors.
    91‑100 Program Management & Sustainability
91. ARPA‑H OLAB Governance Board – Charter, conflict‑of‑interest policies, and decision‑making framework.
92. Integrated Project Schedule & Milestone Tracker – Cloud‑based Gantt dashboard with earned‑value analysis.
93. Risk Management & Mitigation Matrix – Identify technical, regulatory, and financial risks; assign owners.
94. Financial Oversight & Audit Protocol – Quarterly spend reviews and independent audit plan.
95. Intellectual Property (IP) Management Strategy – Patent filing roadmap, licensing options, and revenue sharing.
96. Commercialization Pathway Framework – Stage‑gate model from proof‑of‑concept to FDA clearance.
97. Sustainability Business Model Canvas – Revenue streams (service fees, data licensing, diagnostics sales).
98. Stakeholder Communication Plan – Quarterly newsletter, webinars, and an annual summit.
99. Technology Transfer Office (TTO) Support Unit – Dedicated staff for industry partnerships and SBIR/STTR support.
100. Impact Evaluation & Metrics Dashboard – Track publications, patents, FDA approvals, and health‑outcome improvements.
     All 100 proposal ideas are now listed. Let me know if you need detailed budgets, timelines, specific formatting, or any other information for these ARPA‑H OLAB concepts!